BioForce Nanosciences Holdings, Inc.
BFNH
$0.60
$0.000.00%
OTC PK
| 12/31/2025 | 09/30/2025 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | 1.64% | -5.62% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 1.64% | -5.62% | |||
| Operating Income | -1.64% | 5.62% | |||
| Income Before Tax | -2.33% | 5.62% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.33% | 5.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | -2.33% | 5.62% | |||
| EBIT | -1.64% | 5.62% | |||
| EBITDA | -- | -- | |||
| EPS Basic | 0.00% | 5.41% | |||
| Normalized Basic EPS | 0.00% | 4.35% | |||
| EPS Diluted | 0.00% | 5.41% | |||
| Normalized Diluted EPS | 0.00% | 4.35% | |||
| Average Basic Shares Outstanding | 0.01% | 0.00% | |||
| Average Diluted Shares Outstanding | 0.01% | 0.00% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||